Abstract
Constrictive pericarditis (CP) is a challenging clinical scenario in which the heart muscle is entrapped by thick, fibrous, and frequently calcified pericardial layers. Whereas infectious diseases (mostly bacterial) had been observed as the main etiology in the last decades, nowadays, post-surgical or radiotherapy iatrogenic inflammation is becoming highly prevalent with the exception of developing countries and patients with immunodeficiency in which tuberculosis is still frequently observed. Clinically, progressive dyspnea and peripheral edema are present and frequently considered of unknown origin because of the diagnostic challenge that CP poses. As a matter of fact, a specific knowledge of echocardiography and right heart catheterization is essential to recognize constriction features. Moreover, a valuable support is provided by dedicated imaging modalities (mostly magnetic resonance). Complete surgical removal of the pericardium (pericardiectomy), when feasible and performed early, is associated with excellent symptomatic improvement. Unfortunately, in specific scenarios (radiation therapy) or when surgery is performed after severe constriction development, surgical outcomes are poor, and CP assumes the profile of an end-stage disease. This reinforces the unmet need of early detection of CP and the development of novel therapeutic strategies.
Keywords
- constrictive pericarditis
- right heart catheterization
- pericardiectomy
- heart failure
- restrictive cardiomyopathy
1. Introduction
Constrictive pericarditis (CP), firstly described by Richard Lower in “
2. Etiology
Traditionally, CP had been described months to years after acute bacterial pericarditis, whereas in the last decades, chronic inflammation associated with previous thoracic surgery or radiotherapy has become the most frequent cause of CP. A recent meta-analysis of patients submitted to pericardiectomy for symptomatic CP [2] has collected data about 2114 patients admitted between 1991 and 2019. Idiopathic etiology was present in approximately half of patients (50.2%) followed by post-cardiac surgery (26.2%) and mediastinal radiotherapy (8.9%). Interestingly, studies published after 2000 have reported a dramatic decrease of cases secondary to cardiac surgery with respect to previous reports (15% vs. 33%, p < .001). This could reflect the evolution of cardiac surgery techniques with progressively reduced operative times and close echocardiographic evaluation after surgery.
Moreover, end-stage renal disease, connective tissue disorders (i.e., lupus erythematosus, rheumatoid arthritis, systemic sclerosis, etc.), and pulmonary diseases, including pulmonary asbestosis and mesothelioma infiltrating the pericardium, are less frequent but important causes of CP. More exceptional is CP secondary to transmural myocardial infarction (Dressler’s syndrome), given the spread of primary angioplasty and, consequently, the reduction of infarct size, in developed countries. Finally, CP secondary to tuberculosis infection in developed countries has been reported to be a rare condition (3%) with an increasing trend in the last decades due to imported cases and the spread of HIV infections. Nonetheless, taking into account socioeconomic background, tuberculosis infections and, along with them, late complications like CP are significantly increasing in developing countries. Consequently, tuberculosis has become the first cause of CP in countries of sub-Saharan Africa and few countries of Asia, including India where tuberculosis was associated with more than half of cases of CP (51.6%) in a retrospective single-center analysis, including patients submitted to pericardiectomy between 2009 and 2020 [3].
3. Pathophysiology
Chronic pericardial inflammation usually drives a structural change of pericardial layers, resulting in progressive fibrosis and calcifications and leading to partial adhesions between the layers. Consequently, difficulties in diastolic ventricle filling can be observed. As a matter of fact, during diastole, ventricles experience an active (ATP-consuming) relaxation with a rapid decrease of chamber pressures leading to mitral valve opening and early inflow with a velocity as higher as the pressure gradient between atrial and ventricular chambers. This phase is usually followed by an atrial contraction leading to further ventricle filling with no significant increase of end-diastolic ventricular pressures unless pathologic conditions, like CP, occur. In case of CP, given the reduced compliance of pericardium and its reduced stretching, diastolic pressures of the ventricles rapidly increase, and consequently, ventricular filling abruptly ceases during early to mid-diastole, when cardiac volume reaches the limit set by non-compliant pericardium. Thus, atrial emptying will be incomplete, leading to the increase of atrial and pulmonary/systemic venous pressure [4]. Systemic venous congestion results in hepatic congestion, peripheral edema, and ascites and, if long-standing, in cardiac cirrhosis and symptoms secondary to low cardiac output (Figure 1). As a matter of fact, although left ventricle (LV) ejection fraction is usually normal, the absolute reduction of diastolic filling, due to pericardial reduced compliance, leads to reduced cardiac output and, consequently, to fatigue and reduced functional class. Finally, physiologic reduction of intrathoracic pressure during inspiration acts on lungs and pulmonary veins, as usual, but will not be transmitted to the heart (
4. Clinical “red flags”
When approaching a patient with CP, jugular venous pressure (JVP) increases, with specifically an abnormal increase during inspiration explicated by the incompliance of pericardium that impedes the venous blood, that usually increases because of suction inspiratory forces, to enter into the RV. This phenomenon (
Finally, an essential clinical feature of CP is a
5. Non-invasive imaging “red flags”
The essential technique for non-invasive assessment of CP is echocardiography that, moreover, is widely available and cost-saving. Therefore, it should be considered a first-line exam in patients with suspicion of CP. This is because, beside echocardiography, diagnosis of CP can be challenging with other techniques given the fact that there are no specific findings pathognomonic of pericardial constriction. As a matter of fact, atrial fibrillation at EKG can be a frequent finding in this subset of patients but, given its high prevalence in general population, lacks adequate specificity. On chest X-rays, pericardial calcification is not always seen and, when encountered, is not necessarily an expression of constrictive physiology [9]. Moreover, another useful but not specific marker of CP is pulmonary vascular congestion and redistribution on chest X-rays, secondary to the increase of LV filling pressures. Similarly, a CT scan permits to detect even small spots of pericardial calcification and minor increases of pericardial thickness (>2 mm) [10]. This applies also to MRI, without the need for iodinated contrast or ionizing radiations but with reduced accuracy than CT in detecting small calcifications and measuring thickness (Figure 3). Nonetheless, although pericardial morphology can be described precisely, physiologic repercussions of CP on ventricular diastole cannot be estimated directly and can be only presumed by hepatic venous congestion, ascites, and pleural effusions. A step-forward is obtained by Cine acquisition in which ventricular-wall-motion abnormalities and ventricular-contour distortion secondary to localized adhesions to pericardium (corresponding to areas of major pericardial calcifications) can be visualized, and moreover, ventricular inter-dependence can be derived by leftward interventricular septal shift during early diastole (
Consequently, given the limitations of the aforementioned non-invasive techniques, echocardiography, when feasible (optimal ultra-sonographic window is not always available), is the exam of choice in this subset of patients. Importantly, a respirometer is mandatory in order to detect respirophasic changes of ventricular diastolic filling and septal movements [12].
Similar to Cine CT or MRI, first step of assessment of CP by echocardiography is the observation of thickened pericardium [13], with or without areas of tethering on myocardium, usually at the level of the right free wall, appreciated on sub-costal and apical 4-chambers views. In addition, septal bounce phenomenon during inspiration, a constant finding of CP, can be highlighted as a septal notch in an M-mode long-axis parasternal view [14].
Moreover, dilation of supra-hepatic and inferior vena cava is observed in a sub-costal view in almost all patients with CP.
Central role in echocardiographic assessment of CP is played by Doppler hemodynamic evaluation. Most of the times, Doppler findings can confirm constrictive physiology without the need for invasive confirmation. Mitral and tricuspid inflows are characterized by high early diastolic velocities (E wave) with short deceleration time and significant respiratory variations in 2/3rd of patients [15]. Mitral E wave variation >25% (minimum at the end of inspiration) and tricuspid E wave variation>40% (maximum at the end on inspiration) are considered pathognomonic of CP, although absence of respiratory variation does not exclude the diagnosis (Figure 3). As a matter of fact, the presence of respiratory variations of mitral- and tricuspid-inflow-Doppler patterns alone can be present also without CP, like in patients with severe COPD due to higher respiratory variations of intra-thoracic pressures. Nonetheless, patients with COPD present a marked increase of inferior vena cava and supra-hepatic vein systolic forward flow velocity, whereas in patients with CP, this increase is blunted [16]. It is important to remember that in patients with CP, during inspiration, tricuspid flow is relatively increased with respect to mitral flow, but absolute flow is limited by pericardial constriction and, therefore, cannot increase significantly. A higher positive predictive value (96%) is offered by supra-hepatic-vein-Doppler pattern characterized by a decrease of expiratory diastolic forward velocities with large expiratory diastolic reversals.
Another useful parameter to detect CP is obtained by mitral annular tissue Doppler assessment of early diastolic velocity (e’wave), with evidence of
6. Invasive hemodynamic assessment
Simultaneous right- and left-heart catheterization is currently the gold standard for the diagnosis of CP. Evidence of equalization of end-diastolic pressures (≤ 5 mmHg difference between right- and left-ventricle-end-diastolic pressures secondary to fixed pericardial volume and consequent ventricular interdependence) and the visualization of “square root” or “dip and plateau” sign (secondary to sharp ventricular-pressure increase when pericardial constraining volume is reached immediately after early diastolic inflow) are considered the most important features for the diagnosis [20]. Another important marker of constriction is the presence of significant respiratory variations of LV and RV systolic and diastolic pressures as a consequence of dissociation between intracardiac and intrathoracic pressures (Figure 5). This has been quantified using the
7. Constrictive versus restrictive physiology: differences and similarities
Clinical spectra of CP and RCM frequently overlap given the defect of diastolic ventricle filling that is common to both diseases. Anyway, as a specific treatment for each of them is present, a correct differential diagnosis is mandatory. RCM is characterized by increased myocardial stiffness and, therefore, increased ventricular filling pressures in both the systemic and pulmonary circulations with the increase of both mitral and tricuspid inflows during inspiration. Differently, CP is characterized by discordant respiratory flow variations in RV and LV (
Moreover, non-invasive imaging modalities, like echocardiography, CT scan, and cardiac MRI, are helpful in the diagnostic process as the presence of pericardial calcifications and/or increased pericardial thickness suggest CP, whereas ventricular hypertrophy (with or without delayed gadolinium enhancement at MRI) and marked atrial enlargement suggest RCM. Finally, myocardial tethering by adhered pericardium is present in CP (absent in RCM) and is accompanied by LV shape deformations and/or reduced circumferential restoration and speckle-tracking examination with normal longitudinal restoration. On the contrary, in RCM, circumferential restoration is normal, whereas longitudinal restoration is reduced. Similarly, e’lateral is equal or slower than e’medial in CP (
8. Treatment
Surgical pericardiectomy is the treatment of choice of CP with acceptable outcomes in the long-term [25, 26, 27, 28]. Nonetheless, diuretic therapy is the first-line treatment of CP, often started even before proper diagnosis is obtained, and permits initially to control mild symptoms and reduce venous congestion. Unfortunately, as CP progresses, patients become refractory to diuretics and maintain an adequate cardiac output with compensatory sinus tachycardia. This is the reason why beta-adrenergic blockers, verapamil, and diltiazem should be avoided. In case of high-rate supraventricular arrhythmias, digoxin is the negative chronotropic agent of choice. In the specific subset of patients developing CP early (<3 months) after cardiac surgery, treatment with nonsteroidal anti-inflammatory agents, colchicine, and steroids for at least 3 months has been proposed. Predictors of success of this strategy are increased biomarkers of systemic inflammation (hsCRP) and evidence of significant pericardial inflammation visualized as intense delayed enhancement on MRI [29, 30]. Nonetheless, surgical pericardiectomy should not be delayed in case of failure of initial anti-inflammatory strategy as earlier surgery is associated with improved outcomes. In patients without ongoing acute pericardial inflammation or with long-standing symptoms, surgical pericardiectomy is the first-line treatment. Different surgical approaches have been described (on- versus off-pump, median sternotomy versus mini-invasive thoracotomy) without a clear benefit of one of them. Complete pericardiectomy, defined as extensive excision of pericardium up to superficial epicardium, if involved, anteriorly between the 2 phrenic nerves and from the great arteries superiorly to the diaphragm inferiorly, posteriorly between the left phrenic nerve to the left pulmonary veins, including the diaphragmatic wall of left ventricle, is highly recommended. In case of severe calcification, it can be associated with ultrasound or laser debridement. Moreover, a less invasive approach with multiple transverse and longitudinal incisions on the epicardial layer (
9. Prognosis
Pericardiectomy, if performed early after diagnosis, is usually associated with acceptable quality of life. Symptomatic relief (associated with diastolic function recovery in up to 50% of cases) usually occurs immediately after surgery or, only in a small proportion of patients, after few months [27]. Long-term survival rates, unfortunately, remain moderately acceptable, despite surgical advances in the last decades, as reported in a meta-analysis of patients submitted to pericardiectomy [2] in which pooled all-cause 1-year and 5-year mortality rates after pericardiectomy were 17.4% and 32.7%, respectively. Interestingly, patients enrolled after 2000 had higher 1-year and 5-year all-cause mortality rates compared with before 2000 (19.8% vs. 10%, p = 0.01, and 49.4% versus 20%, p < 0.001, respectively). This possibly reflects the shift that occurred in the last decades toward more complex and recurrent etiologies of CP like cardiac surgery or mediastinal radiotherapy. As a matter of fact, patients with CP secondary to cardiac surgery have significantly higher risk of all-cause mortality after pericardiectomy when compared with patients with idiopathic etiology (HR: 2.15; 95% CI: 1.21 to 3.61, p = 0.01), with even worse outcomes when CP secondary to radiotherapy is compared with idiopathic etiology (HR: 3.21; 95% CI: 1.56 to 6.50, p < 0.01) [2]. Finally, pericardiectomy performed in patients with CP secondary to tuberculosis, the most common etiology observed in developing countries, has been recently reported to have similar outcomes with respect to other etiologies, although with more technical complexity in terms of increased operative time, more blood loss, and prolonged ICU and hospital stay [3].
10. Conclusion
Diagnosis of CP in the context of patients with signs and symptoms of heart failure can be challenging, and frequently, distinguishing it from RCM can be difficult. Firstly, thinking about CP when evaluating patients with diastolic dysfunction, most of all after cardiac surgery or mediastinal radiotherapy, is crucial to recall in our minds all the characteristics of CP and make it possible to address the correct diagnosis. CP should also be suspected when ventricular filling restrictions are observed few months after a tuberculosis infection, taking into account that tuberculosis is the first cause of CP in countries of sub-Saharan Africa and few countries of Asia.
Secondly, the use of multimodality imaging is the cornerstone for the diagnosis of CP and the evaluation of the extension of the disease and, finally, to guiding surgical treatment. In doubtful cases, we should not hesitate to ask for invasive pressure assessment, safe and diagnostic in the majority of the cases. Finally, long-terms results of surgery in patients with chronic end-stage disease are poor, most of all when CP is secondary to previous cardiac surgery or radiation therapy, also with less invasive surgical strategies like
Acronyms and abbreviations
CP | constrictive pericarditis |
RCM | restrictive cardio-myopathy |
LV | left ventricle |
RV | right ventricle |
JVP | jugular venous pressure |
CT | computed tomography |
MRI | magnetic resonance imaging |
hsCRP | high sensitive C reactive protein |
NYHA | New York Heart Association |
References
- 1.
Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC). European Heart Journal. 2015; 36 :2921 - 2.
Tzani A, Doulamis IP, Tzoumas A, et al. Meta-analysis of population characteristics and outcomes of patients undergoing Pericardiectomy for constrictive pericarditis. The American Journal of Cardiology. 2021; 146 :120-127 - 3.
Benjamin SR, Mohammad A, Shankar R, et al. Does tuberculosis affect surgical outcomes following pericardiectomy for chronic constrictive pericarditis? Twelve years’ experience from a tertiary care center in India. Indian Journal of Thoracic Cardiovascular Surgery. 2022; 38 (3):241-250 - 4.
Vistarini N, Chen C, Mazine A, et al. Pericardiectomy for constrictive pericarditis: 20 years of experience at the Montreal Heart Institute. The Annals of Thoracic Surgery. 2015; 100 :107 - 5.
Ling LH, Oh JK, Schaff HV, et al. Constrictive pericarditis in the modern era: Evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation. 1999; 100 :1380-1386 - 6.
Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician’s Rosetta Stone. Journal of the American College of Cardiology. 1997; 30 :8-18 - 7.
Park JY, Eleid MF, Michelena HI. Abnormal neck veins. JAMA Cardiology. 2016; 1 :487-488 - 8.
Hancock EW. Differential diagnosis of restrictive cardiomyopathy and constrictive pericarditis. Heart. 2001; 86 :343-349 - 9.
Austin JH. The lateral chest radiograph in the assessment of nonpulmonary health and disease. Radiologic Clinics of North America. 1984; 22 :687-698 - 10.
Bull RK, Edwards PD, Dixon AK. CT dimensions of the normal pericardium. The British Journal of Radiology. 1998; 71 :923-925 - 11.
Gahide G, Granier M, Frapier JM. Effusive constrictive pericarditis: Functional and anatomical magnetic resonance findings. European Heart Journal. 2009; 30 :1371 - 12.
Welch TD, Ling LH, Espinosa RE, et al. Echocardiographic diagnosis of constrictive pericarditis: Mayo Clinic criteria. Circulation. Cardiovascular Imaging. 2014; 7 :526-534 - 13.
Ling LH, Oh JK, Tei C, et al. Pericardial thickness measured with transesophageal echocardiography: Feasibility and potential clinical usefulness. Journal of the American College of Cardiology. 1997; 29 :1317-1323 - 14.
Coylewright M, Welch TD, Nishimura RA. Mechanism of septal bounce in constrictive pericarditis: A simultaneous cardiac catheterisation and echocardiographic study. Heart. 2013; 99 :1376 - 15.
Hurrell DG, Nishimura RA, Higano ST, et al. Value of dynamic respiratory changes in left and right ventricular pressures for the diagnosis of constrictive pericarditis. Circulation. 1996; 93 :2007-2013 - 16.
Boonyaratavej S, Oh JK, Tajik AJ, et al. Comparison of mitral inflow and superior vena cava Doppler velocities in chronic obstructive pulmonary disease and constrictive pericarditis. Journal of the American College of Cardiology. 1998; 32 :2043-2048 - 17.
Reuss CS, Wilansky SM, Lester SJ, et al. Using mitral ‘annulus reversus’ to diagnose constrictive pericarditis. European Journal of Echocardiography. 2009; 10 :372-375 - 18.
Ha JW, Oh JK, Ling LH, et al. Annulus paradoxus: Transmitral flow velocity to mitral annular velocity ratio is inversely proportional to pulmonary capillary wedge pressure in patients with constrictive pericarditis. Circulation. 2001; 104 :976-978 - 19.
Verhaert D, Gabriel RS, Johnston D, et al. The role of multimodality imaging in the management of pericardial disease. Circulation. Cardiovascular Imaging. 2010; 3 :333 - 20.
Talreja DR, Nishimura RA, Oh JK, et al. Constrictive pericarditis in the modern era: Novel criteria for diagnosis in the cardiac catheterization laboratory. Journal of the American College of Cardiology. 2008; 51 :315-319 - 21.
Nishimura RA, Carabello BA. Hemodynamics in the cardiac catheterization laboratory of the 21st century. Circulation. 2012; 125 :2138-2150 - 22.
Sorajja P. Invasive hemodynamics of constrictive pericarditis, restrictive cardiomyopathy, and cardiac tamponade. Cardiology Clinics. 2011; 29 :191-199 - 23.
Rajagopalan N, Garcia MJ, Rodriguez L, et al. Comparison of new Doppler echocardiographic methods to differentiate constrictive pericardial heart disease and restrictive cardiomyopathy. The American Journal of Cardiology. 2001; 87 :86-94 - 24.
Leone O, Veinot JP, Angelini A, et al. 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovascular Pathology. 2012; 21 :245-274 - 25.
Gopaldas RR, Dao TK, Caron NR, Markley JG. Predictors of in-hospital complications after pericardiectomy: A nationwide outcomes study. The Journal of Thoracic and Cardiovascular Surgery. 2013; 145 :1227 - 26.
Tokuda Y, Miyata H, Motomura N, et al. Outcome of pericardiectomy for constrictive pericarditis in Japan: A nationwide outcome study. The Annals of Thoracic Surgery. 2013; 96 :571 - 27.
Biçer M, Özdemir B, Kan İ, et al. Long-term outcomes of pericardiectomy for constrictive pericarditis. Journal of Cardiothoracic Surgery. 2015; 10 :177 - 28.
Busch C, Penov K, Amorim PA, et al. Risk factors for mortality after pericardiectomy for chronic constrictive pericarditis in a large single-Centre cohort. European Journal of Cardio-Thoracic Surgery. 2015; 48 :e110 - 29.
Feng D, Glockner J, Kim K, et al. Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: A pilot study. Circulation. 2011; 124 :1830-1837 - 30.
Mayosi BM, Ntsekhe M, Bosch J, et al. IMPI trial investigators. Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. The New England Journal of Medicine. 2014; 371 :1121-1130 - 31.
Azam S, Hoit BD. Treatment of pericardial disease. Cardiovascular Therapy. 2011; 29 :308 - 32.
Matsuura K, Mogi K, Takahara Y. Off-pump waffle procedure using an ultrasonic scalpel for constrictive pericarditis. European Journal of Cardio-Thoracic Surgery. 2015; 47 :e220